ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 306 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is 1.19 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $380,706 | -27.6% | 10,676 | -48.4% | 0.05% | -20.0% |
Q1 2023 | $525,678 | -72.1% | 20,696 | -63.6% | 0.06% | -70.7% |
Q3 2022 | $1,881,000 | +27.8% | 56,917 | +36.1% | 0.20% | +41.4% |
Q2 2022 | $1,472,000 | +161.5% | 41,815 | +241.3% | 0.14% | +141.7% |
Q1 2022 | $563,000 | – | 12,251 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 908,474 | $24,410,696 | 22.12% |
Western Financial Corp/CA | 820,239 | $22,039,822 | 16.16% |
JOHNSON & JOHNSON | 247,598 | $6,652,958 | 2.45% |
WEALTH EFFECTS LLC | 164,750 | $4,426,835 | 2.19% |
M28 Capital Management LP | 67,400 | $1,811,038 | 2.08% |
Privium Fund Management B.V. | 259,036 | $6,960,298 | 2.07% |
Evolutionary Tree Capital Management, LLC | 51,266 | $1,377,517 | 1.78% |
Avidity Partners Management LP | 1,063,897 | $28,586,912 | 1.15% |
SECTORAL ASSET MANAGEMENT INC | 157,552 | $4,233,422 | 0.82% |
Vivo Capital, LLC | 137,411 | $3,692,234 | 0.40% |